Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-17 to 2025-09-18
Current total value of award: $4346.15
Description: 4569494987!QUILLIVANT XR 25 MG/5 ML SUSP 120ML